In2Care
In2Care, founded in 2011 in the Netherlands and now a product brand of Envu (Environmental Science U.S. LLC), develops the In2Care Mosquito Station — a biological mosquito control device that leverages mosquito oviposition behavior to reach hard-to-access breeding sites, sold to professional pest management operators across multiple countries.
- Company typePrivate
- Founded2011
- HeadquartersNijmegen, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What In2Care does
In2Care, founded in 2011 and headquartered in Nijmegen, Netherlands, develops an innovative and sustainable mosquito control product — the In2Care Mosquito Station. The station exploits the natural oviposition behavior of mosquitoes: when egg-laying female mosquitoes visit the device, they pick up control agents and subsequently distribute them to breeding sites that are typically hard to reach through conventional spraying. This biological mechanism delivers continuous 24/7 reduction of both adult mosquitoes and larvae while minimizing impact on non-target organisms, positioning the product for use in sensitive outdoor environments.
In2Care operates today as a product brand under Envu (Environmental Science U.S. LLC), a Cary, North Carolina-based environmental science organization backed by more than 50 years of category experience. The Mosquito Station is sold hardware-style through Envu's direct enterprise field-sales channel, accessed via a consultative inquiry form on the Envu corporate website. Pricing is not publicly disclosed; customers engage Envu experts to assess suitability by country and use case. Active distribution spans at least nine countries (USA, Brazil, Hong Kong, Israel, Mauritius, Philippines, Saudi Arabia, Singapore, Thailand), and the brand is a registered trademark owned by Environmental Science U.S. LLC.
The customer base comprises professional pest management operators and mosquito control specialists serving sensitive outdoor environments where precision targeting and non-target organism protection are required. In2Care is privately held as a wholly owned product line within Envu, with an internal leadership team consisting of CEO Marius Waard and co-founders Marit Farenhorst (R&D), Anne Osinga, and Remco Suer. The company received $10.2 million in funding from the Bill & Melinda Gates Foundation in December 2015, indicating public-health validation of the technology's relevance to disease-vector control programs.
In2Care firmographics
Firmographics- Name
- In2Care
- Legal name
- Environmental Science U.S. LLC
- Website
- https://in2care.org
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- In2Care, founded in 2011 in the Netherlands and now a product brand of Envu (Environmental Science U.S. LLC), develops the In2Care Mosquito Station — a biological mosquito control device that leverages mosquito oviposition behavior to reach hard-to-access breeding sites, sold to professional pest management operators across multiple countries.
- Ownership category
- akta.pro rank
In2Care industry classification
Industry- Product category
- Mosquito Control Products
- NAICS
- Exterminating and Pest Control Services (561710)
- akta.pro primary industry
- In2Care/Trap-Based Mosquito Control (Targeted Trapping) (HSAMAEAG)
- akta.pro secondary industries
- Monthly/Recurring Mosquito Control Programs (HSAMAEAB), Mosquito Control Products (Larvicides, Dunks, Foggers) (CRAJAHAI)
Keywords
Where In2Care is headquartered
LocationHeadquarters
- HQ city
- Nijmegen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
In2Care business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Mosquito Station Hardware and Products: In2Care Mosquito Station appears to be sold as a physical product (hardware station) for mosquito control. The revenue model likely involves one-time product sales and/or recurring product replenishment cycles for continuous mosquito control in outdoor environments.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
In2Care product offering
Product offeringCore offering
In2Care develops and supplies the In2Care Mosquito Station, a physical biological mosquito control device designed for sensitive outdoor environments. The station uses egg-laying mosquitoes themselves to spread control agents to hard-to-reach breeding sites, simultaneously reducing adult mosquito populations and larvae over time. The product is sold through Envu's global direct sales network as part of its Mosquito Management segment.
Product overview
In2Care offers a single unified product: the In2Care Mosquito Station. This is a mosquito control device designed for sensitive outdoor environments where precision mosquito control is needed. The station operates continuously (24/7) and minimizes impact on non-target organisms. It is part of Envu's Mosquito Management segment.
Differentiator
Problem solved
Functional benefit
Products and services
- In2Care Mosquito Station An innovative mosquito control station that leverages mosquito behavior to reduce mosquito populations. When egg-laying mosquitoes visit the station, they help spread control agents to breeding sites that are typically hard to reach, reducing both adult mosquitoes and larvae over time. Provides continuous 24/7 control and minimizes impact on non-target organisms, designed for sensitive outdoor environments requiring precision mosquito control.
Companies that use In2Care
Customer profileSegments2 records
Ideal customer profiles1 record
In2Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
In2Care partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
In2Care competitors and assessment
Company assessmentDirect peers
- ADAPCO: ADAPCO manufactures and distributes mosquito control products (larvicides, adulticides, equipment) to public health and pest management professionals. Comparable to In2Care as both sell chemical/biological control inputs into the same professional mosquito management channel.
- Summit Chemical Company: Summit Chemical produces mosquito control products such as Bti-based larvicides (e.g., FourStar, Natular) used in professional and public health mosquito programs. Highly comparable as a product competitor serving the same professional channel with biological and chemical control solutions.
- Central Life Sciences: Central Life Sciences (a division of Wellmark International) markets vector control products including FourStar briquets and VectorMax mosquito larvicides used by professional mosquito control programs. Directly comparable as a competing product line targeting the same professional buyer.
- Starbar Products: Starbar Products (part of Central Garden & Pet) produces mosquito control traps, attractants, and devices for residential and professional use. Comparable to In2Care as a competing device-based mosquito control solution.
- MGK (McLaughlin Gormley King): MGK manufactures botanical and synthetic insect control products for professional pest management including mosquito control formulations. Comparable as a competing supplier of insect control active ingredients and products to the same professional channel.
- Clarke: Clarke is a leading US provider of professional mosquito control services and products, including larvicides and adulticides. It is directly comparable to In2Care as both target professional mosquito management operators with control solutions for public health and residential markets.
Broad incumbents
- AMVAC Chemical Corporation: AMVAC offers a portfolio of vector and pest control products used in public health and professional mosquito management. Comparable as a broader incumbent with overlapping product categories targeting the same end buyers.
- SC Johnson (OFF! / Raid Yard & Garden): SC Johnson offers widely distributed consumer mosquito control products (OFF!, Raid Yard & Garden). Comparable as a broad incumbent covering the same mosquito control category, though focused on consumer rather than professional/sensitive-environment use cases.
- Valent BioSciences: Valent BioSciences is a global leader in biorational products including the VectoBac line of Bti-based mosquito larvicides. Comparable to In2Care as a broader incumbent selling biological control agents into the same professional mosquito management market.
Emerging players
- BioGents: BioGents develops trap-based mosquito monitoring and control systems with proprietary lure technology, frequently used in research and surveillance applications. Comparable to In2Care as a device/trap-based mosquito control peer, though more focused on surveillance than continuous population reduction.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
In2Care social profiles
Digital presenceIn2Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
In2Care leadership team
Management profileNumber of profiles
Profiles4 records
In2Care funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
In2Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about In2Care
What does In2Care do?
In2Care develops and supplies the In2Care Mosquito Station, a physical biological mosquito control device designed for sensitive outdoor environments. The station uses egg-laying mosquitoes themselves to spread control agents to hard-to-reach breeding sites, simultaneously reducing adult mosquito populations and larvae over time. The product is sold through Envu's global direct sales network as part of its Mosquito Management segment.
Is In2Care a public or private company?
In2Care is a private company. It is classified as corporate owned and is currently operating.
When was In2Care founded?
In2Care was founded in 2011. It employs 1 to 10 people.
Where is In2Care based?
In2Care is headquartered in Nijmegen, Netherlands, in the Europe region.
How does In2Care make money?
One revenue line is on record: mosquito Station Hardware and Products.
Who are In2Care's main competitors?
Direct peers on record are ADAPCO, Summit Chemical Company, Central Life Sciences, Starbar Products, MGK (McLaughlin Gormley King) and Clarke. Broad incumbents are AMVAC Chemical Corporation, SC Johnson (OFF! / Raid Yard & Garden) and Valent BioSciences. BioGents is listed as an emerging player.
Does In2Care have an API?
No public API is recorded for In2Care.
What industry is In2Care in?
In2Care's product category is Mosquito Control Products. Its primary akta.pro industry code is HSAMAEAG, In2Care/Trap-Based Mosquito Control (Targeted Trapping), with a secondary code of HSAMAEAB, Monthly/Recurring Mosquito Control Programs. Its NAICS code is 561710.